Search for:

AI and IoT driven Disruption of Inventory Managementin a Healthcare Institution: An Indian Story

Sourabh Das
CTO, Co-founder & Partner

The Night The Storeroom Became a Waiting Room

At 2:15 am in a district hospital somewhere between Patna and Ranchi, the emergency
ward is full, the pharmacy shutter is half open, and a nurse is searching for an injectable
antibiotic that the online system is showing as available. The shelf, however, is telling a
diBerent story. Two cartons are empty, one carton is misplaced, and another contains
vials expiring in three days. A junior doctor is waiting beside the concerned patient’s bed
while the storekeeper, awakened by phone, has opened a handwritten register. For the
patient’s family, this is not a supply-chain failure; it is a delay in care delivery.

This scene is familiar across India’s healthcare system. India’s hospitals operate in an
irony. The country is a global pharmaceutical powerhouse, supplying a large share of the
world’s generic medicines and vaccines. Yet there are many institutions still struggling
with stockouts, overstocking, expiry losses, cold-chain gaps, fragmented procurement,
and low visibility beyond the central store. Publicly available sector specific estimates
show that India’s healthcare market and hospital sector are expanding rapidly, while
government and private institutions are under pressure to improve accessibility,
aBordability, and reliability. Under this scenario, inventory management is no longer a
back-oBice function. It is becoming a clinical, financial, and ethical capability.

The upcoming disruption is not a single software upgrade. It is the convergence of AI, IoT
devices, barcodes, RFID, temperature sensors, interoperable hospital systems, and
national digital-health infrastructure. Together, they can turn the hospital storeroom into
a living nervous system: sensing consumption, predicting demand, warning of expiry,
protecting temperature-sensitive supplies, and reallocating stock before scarcity is
visible at the bedside.

From Registers to Real-Time: Why Indian Healthcare Institutions Are Ready for Disruption

For decades, inventory control in many public healthcare institutions and clinics has
depended on human memory, periodic stock counts, vendor relationships, reactive
replenishment and spreadsheet-based ordering. This model worked when hospitals
were smaller, formularies were simpler, and patient flows were more predictable. It is
becoming fragile in modern India, where tertiary hospitals, diagnostics chains, public
health facilities, and specialty clinics handle large patient volumes, seasonal disease
complex consumables, implants, vaccines, blood products, high-value devices,
and emergency procurement.

The Ayushman Bharat Digital Mission (ABDM) has already pushed the idea that Indian
healthcare needs an open, interoperable digital ecosystem rather than isolated
systems. Its architecture emphasizes health facility registries, health professional
registries, common standards, and data exchange. Although ABDM is primarily
associated with patient records and identity, it has deeper implication for operations
due to standardized digital workflows. The inventory data can be linked with admissions,
prescriptions, procedures, laboratory demand, pharmacy dispensing, insurance claims,
and public-health reporting.

At the same time, Indian states and public-health partners are investing in supply-chain
visibility. Initiatives are designed to move facilities away from paper-based indenting
toward real-time stock dispensation, auto-indenting, scientific forecasting, and
warehouse optimization. Drug and vaccine distribution management systems are an
example of that. It shows that the bottleneck is not only procurement but visibility as
well. A medicine that exists in a district warehouse but cannot be located, tracked, or
moved before expiry is functionally unavailable.

This is where AI and IoT change the rules of hospital inventory. While IoT answers the
question, “Where is the item and what condition is it in?”, AI answers the question, “What will
be needed next, where, and when?”. In an Indian hospital, that combination can be applied
to five high-impact inventory categories: essential medicines, surgical consumables,
implants and high-value devices, cold-chain products such as vaccines and injectables,
and biomedical equipment spares.


The New Inventory Intelligence: How AI and IoT Could Work in a Healthcare Setting

Now imagine the same hospital one year later. Every carton entering the central store is
scanned. Critical medicines carry batch and expiry information. Refrigerators storing
vaccines and insulin transmit temperature readings every few minutes. Surgical trays are
tagged. The pharmacy system records consumption by ward and department. The
hospital information system knows admissions, diagnoses, procedures, seasonal
trends, and appointment loads. The AI engine does not “guess” the next order; it learns
from dengue season, obstetric case load, orthopaedic surgery schedules, local disease
patterns, supplier lead times, and historical consumption.

The first disruption is demand forecasting. Instead of ordering antibiotics, IV fluids,
gloves, sutures, and reagents on fixed monthly averages, an AI-enabled system can
create dynamic forecasts. During monsoon months, it may anticipate higher use of
platelet bags, dengue test kits, fluids, and antipyretics. Before a scheduled cataract
camp or orthopaedic surgery block, it may alert the store about lenses, implants, sterile
drapes, and anaesthesia consumables. For public hospitals, this would reduce
emergency purchases. For private hospitals, it would release working capital locked in
slow-moving inventory.

The second disruption is expiry prevention. In many hospitals and health care centers,
expiry is discovered during audits, not prevented during operations. AI can rank stock by
risk: slow-moving, high-value, short-expiry, temperature-sensitive, or departmentspecific.
It can recommend transfers from a low-use facility to a high-use facility, trigger
alerts to pharmacists, and support first-expiry-first-out discipline. Within the hospital
network, the system can identify that an oncology drug available in one branch has low
probability of use while another branch has an upcoming cycle of chemotherapy.

The third disruption is cold-chain integrity. India’s vaccine and injectables ecosystem
depends on trust in temperature control. IoT sensors can continuously monitor
refrigerators, cold boxes, and transport containers. If a refrigerator door remains open, a
generator fails, or temperature crosses a threshold, alerts can go to the pharmacist,
biomedical engineer, and facility administrator. Over time, AI can identify recurring
equipment failures or risky storage locations. This is not only about saving inventory; it is
about preventing compromised products from reaching patients.

The fourth disruption is procurement intelligence. AI can compare supplier lead
times, order fulfilment rates, price variation, defect history, and emergency purchase
frequency. It can warn that a low-cost supplier becomes expensive when late deliveries
force local buying. It can support tender planning by showing true consumption rather
than inflated demand from departments that fear stockouts. In India, where hospital
margins, public budgets, and patient aBordability are tightly linked, procurement
intelligence can become a source of both eBiciency and equity.

Indian Signals and References: The Disruption Has Already Begun

The most powerful examples in healthcare are often not branded as “AI transformation.”
They begin as visibility projects. The supply-chain digitization of public health across
Indian states shows how real-time stock information, facility-level ordering, and autoindenting
can reduce the blind spots, causing both stockouts and wastage. A primary
health centre in Assam using mobile stock dispensation is more than a technology pilot;
it is a preview of an inventory model where the last mile speaks back to the warehouse.
Another signal comes from India’s broader health-tech ecosystem. Market analyses
indicates rapid growth in healthcare supply-chain management solutions, driven by
cloud systems, inventory optimization, automation, real-time tracking, and the need for
uninterrupted access to essential medical supplies. Private hospital chains, diagnostics
networks, pharmacy platforms, and device distributors are under competitive pressure to
digitize because patients now compare experience, availability, and speed across
providers.

Hospital leaders often invest first in visible clinical technologies, while inventory
systems remain underfunded. However, AI adoption in Indian healthcare is now moving
beyond clinical decision support. Reports on generative AI highlight productivity gains in
non-clinical operations, including supply-chain management, workforce eBiciency,
predictive analysis, and administrative workflows. The emerging business case reframes
inventory as a patient-safety layer and a margin-protection layer.
Consider a teaching hospital in a Tier-II Indian city. Its pharmacy handles high-volume
generics, emergency drugs, and specialty medicines. Its OTs consume implants and
sterile supplies. Its laboratories need reagents with strict expiry and storage conditions.
Its biomedical department maintains ventilators, monitors, infusion pumps, and
sterilizers. If AI and IoT are integrated across these nodes, the hospital can move from
“department-wise stock ownership” to “institution-wide inventory orchestration”. Some
example benefits can be “solving the shortage in one ward by redistribution before purchase”,
“ordering a machine part before breakdown”, “fixing a cold-room fault before spoilage”,
“consumption of a slow-moving medicine before expiry”, etc.

The disruption will not be limited to large hospitals. In rural and semi-urban India, where
staB are stretched and manual reporting is burdensome, simple IoT and AI-enabled
tools may be even more valuable. While a mobile-first stock system can help auxiliary
nurse, pharmacist or PHC medical oBicer record consumption without duplicating
paperwork, the district public health dashboard can identify facilities with high malaria
kit consumption, low iron-folic acid stock, or abnormal vaccine wastage. AI gives the
local team a sound visibility and transformative power without replacing local decision.

What Leaders Must Get Right: Data, Trust, Governance, and People

The success of this disruption is not linked to cheap sensors or fancy dashboards, but
trust in the outcome. If nurses do not trust the stock balance, they will hoard supplies in
cupboards. Similarly, if doctors do not trust availability, they will prescribe alternatives.
Likewise, if pharmacists fear of stockouts, they may over-indent. For a successful
adoption, AI has to be treated as support mechanism and not a surveillance tool.

Indian healthcare institutions should therefore begin with four leadership choices.

  1. Creation of clean master data – It should include standard item names, units of
    measure, batch numbers, expiry dates, supplier codes, storage conditions, and
    department mappings. AI will not be able to produce reliable forecasts from
    chaotic item lists.
  2. Connecting inventory with clinical workflows – Consumption should be linked
    to prescriptions, procedures, admissions, and diagnostics wherever appropriate.
  3. Design of governance – Governance to be designed around patient safety, privacy,
    cybersecurity, auditability, and accountability. Public opinions about AI in Indian
    healthcare increasingly emphasize on data supply chains, auditability, and
    responsible deployment.
  4. Investment in people – Storekeepers, pharmacists, nurses, biomedical engineers,
    and procurement officers must be trained as digital operators, not treated as
    obstacles to automation.


In the near future, we can expect to see a hospital command centre displaying medicine
availability, OT consumable readiness, cold-chain health, supplier risk, equipment
uptime, and expiry exposure. The system will recommend actions, but humans approve
them. It will explain any higher demand expectation over the upcoming weeks and flag
uncertainty instead of hiding it. The system will continuously learn from local realities
like festival closures, flood-aBected roads, seasonal outbreaks, insurance camp
volumes, and doctor rosters.

For Indian healthcare, the promise is profound. AI and IoT can reduce waste, improve
availability, protect cold-chain integrity, cut emergency purchases, support equitable
distribution, and free clinicians from avoidable delays. But the greatest disruption is in
the mindset where inventory will not be seen as a warehouse problem, instead be
understood as part of care delivery. The patient in the emergency ward may never know
that a forecast, a sensor, a barcode, and a redistribution alert have worked together
before midnight, with the inventory system remaining invisible at the bedside.

A consultative perspective for leaders serving the financial MSME sector in India to create the competitive advantage in building customer trust while meeting regulatory compliance mandate

DPDP Compliance: The Next Trust Test for India’s Small and Medium Sized Financial Institutions

Sourabh Das
CTO, Co-founder & Partner

Let us picture the operational landscape of a mid-sized NBFC in India on a busy Monday. During the morning the leadership team is focused on loan growth, collection efficiency, partner integrations and investor reporting. Then around noon, the Compliance Head receives a customer complaint regarding likely sharing of his/her KYC document with a third-party collection partner without clear notice, consent trail or documented purpose limitation. By evening, the technology team discovers that similar customer records have moved across loan origination systems, spreadsheets, WhatsApp workflows, field level apps, cloud folders and vendor dashboards.

There was not a single malicious act or occurrence of any out-of-the-box and surprise activity. In spite of that the institution now faces the exact kind of privacy risk that India’s Digital Personal Data Protection Act (DPDP), 2023 is designed to address when personal data is collected, processed, shared, retained and secured without demonstrable accountability. For small and medium-sized financial institutions, the DPDP mandate by the Government of India is not merely a legal statute. It is a test of whether customers, regulators, lenders, partners and investors can trust the institution’s operating model.

The Indian Lesson – Privacy Risk is Already a Financial Services
Risk

India has already moved beyond theoretical privacy principles. The DPDP framework introduces monetary penalty exposure that can reportedly reach up to ₹250 crore for serious failure such as inadequate security safeguards leading to personal data breach.
At the same time, the Reserve Bank of India’s “Digital Lending Directions 2025” specifically recognises risks in digital lending around areas like uncontrolled third-party engagement, breach of data privacy, customer protection, grievance redressal, data
collection, data sharing, storage and privacy policies.

This means a small lender, co-operative bank, fintech partner, credit service provider or insurance distributor cannot treat DPDP as a separate legal project. The same customer data that powers KYC, credit underwriting, fraud checks, collections, service calls, colending arrangements and cross-sell campaigns can also become the source of regulatory exposure, reputational damage and business interruption.

The fear factor is not only the amount of fine but the chain reaction associated with it. A privacy failure can force management to stop campaigns, suspend partner data transfers, revisit vendor contracts, investigate historic processing, respond to customer
requests, notify authorities, reassure lenders, brief the board and rebuild customer confidence. For any institution that is running lean operations, this kind of disruption can cost more than the compliance program being postponed or overlooked.

The commercial implication shows clearly that DPDP readiness is becoming part of financial institution’s credibility. Institutions that cannot suitably prove how they collect, use, share, retain and protect customer data, may find themselves less attractive to
banks, fintech platforms, payment partners, account aggregator ecosystems, investors and outsourcing parties.

The Business Story – A Privacy Gap Can Break Four Things at Once

  1. Balance Sheet – DPDP penalty exposure, remediation costs, forensic reviews, legal support, customer notification, technology fixes and lost business can become a material financial event. For a small or medium-sized financial
    institution, this can a􀆯ect profitability, capital planning and investor confidence.
  2. Trust – Customers may let o􀆯 a service delay based on a proper justification, but they are far less forgiving when identity documents, bank details, income information or loan records are mishandled. In financial services, trust is more than a brand attribute; it has become the operating license to keep deposits, repayments, referrals and relationships thriving.
  3. Operations – A privacy incident can force teams to trace data across systems, vendors, branches, agents and archives. It can expose the gaps related to absence of data inventories, consent logs, retention rules, breach protocols, grievance workflows and accountable owners. The seemingly legal issue will then quickly change into an command-centre operations problem.
  4. Interoperability – Financial institutions increasingly operate through APIs, digital lending apps, lending service providers, account aggregators, payment systems, credit bureaus, co-lending partners and outsourced processors. In this connected environment, one weak privacy position can slow onboarding, trigger additional due diligence or cause larger partners to reconsider the relationship.

The Hidden Aspect – Most Institutions Do Not Know Their Real Data
Story

If you ask a leadership team regarding where its customer personal data resides, the first answer is most likely the core banking system, loan origination platform or CRM. Then, after a proper assessment, there can be a more uncomfortable second answer
like email inboxes, spreadsheets, shared folders, third-party dashboards, call-centre recordings, collection agency files, archived databases, WhatsApp conversations and employee devices.

This is where DPDP compliance becomes a business transformation exercise. The institution must move from assumed control to evidenced control. It must know the following – what data it collects, why it collects it, where it stores it, who accesses it, which vendors process it, how long it is retained, how consent is captured, how withdrawal is honoured, how grievances are handled and how breaches are escalated.

The Required Journey – From Awareness to Assurance

  1. Awareness building: The board, founders, senior management, business heads, technology teams, operations teams, compliance teams and frontline staff must understand DPDP in their own language. The following are few of the examples –
    – A collection agent needs to know what not to share
    – A product manager needs to know how consent affects journeys
    – A technology lead needs to know what evidence will be required
    – A board member needs to know the business consequence of delay
  2. Current-state assessment: The institution needs a structured review of data flows, notices, consent mechanisms, legitimate uses, third-party processing, security safeguards, retention, deletion, breach readiness, grievance handling and governance ownership. The output should be a clear mapping matrix of gap analysis.
  3. Maturity roadmap and handholding: DPDP readiness must be classified into practical milestones like quick wins, high-risk remediations, policy and SOP updates, consent redesign, vendor contract strengthening, training roll-out, breach playbook testing and management reporting. An external expert-led consultation can provide the independence, methodology and execution discipline required to convert compliance from a document into an operating capability.

Our Viewpoint – Do Not Wait for the First Incident to Discover the
Gaps

The institutions that act early will turn DPDP into a market signal: “We are safe to partner with, safe to lend through, safe to invest in and safe for customers to trust.” The institutions that delay may discover DPDP through a possibly negative route like a
customer complaint, a breach, a partner audit, a regulator query or a board-level crisis.

The institutions can think of launching a 60-75 day DPDP readiness sprint led by a team of external experts, covering awareness workshops, current-state assessment, risk prioritisation, maturity roadmap creation and implementation handholding. In the DPDP
era, privacy maturity is not back-office compliance, it is rather a strategy for business continuity, trust and interoperability.